Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
The series is primarily intended to document the disease classifications used in the Population Health Impact of Disease in Canada (PHI) research program and help researchers to understand how the PHI estimates were calculated. It is also of interest to health professionals, advocacy groups, and in…
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
Strategy's priorities:; Priority 1 - Decrease the risk of people getting cancer.; Priority 2 - Diagnose cancer faster, accurately and at an earlier stage.; Priority 3 - Deliver high-quality care in a sustainable, world-class system.; Priority 4 - Eliminate barriers to people getting the care they n…
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency ARHCC Library REF | Available | ||
c.1 BC Cancer Agency KEL Library REF | Available | ||
c.1 BC Cancer Agency SUR Library REF | Available | ||
c.1 BC Cancer Agency VC Library REF-Directories | Available |
Based on presentations from the American Society of Hematology 49th Annual Meeding and Exposition, December 8-11, 2007, Atlanta, Georgia
c.1 BC Cancer Agency VAN Library | Available |
This publication represents the views and expert; opinions of an IARC Working Group on the; Evaluation of Carcinogenic Risks to Humans,; which met in Lyon, October 2013
c.1 BC Cancer Agency VAN Library REF Statistics | Available |
v.1: Mobilizing science and technology to Canada's advantage; v.2: Realiser le potentiel des sciences et de la technologie au profit du Canada; v.3: Mobilizing science and technology to Canada's advantage : summary
c.1 BC Cancer Agency VAN Library REF Statistics | Available |
This publication represents the views and expert; opinions of an IARC Working Group on the; Evaluation of Carcinogenic Risks to Humans which met in Lyon , 3-10 June 2014.
c.1 BC Cancer Agency VAN Library | Available |